Armistice Capital, Llc Tetraphase Pharmaceuticals Inc (TTPH) insider trading activity

Armistice Capital, LLC is Director of TETRAPHASE PHARMACEUTICALS INC. Currently has a direct ownership of 0 shares of TTPH, which is worth approximately $0. The most recent transaction as insider was on Jul 28, 2020, when has been sold 1,419,507 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

0% 12M change

Total Value Held $0

ARMISTICE CAPITAL, LLC Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Jul 28 2020	SELL Other acquisition or disposition	-	1,419,507 Reduced 100.0%	0 Common Stock

Also insider at

SAVA

CASSAVA SCIENCES INC Healthcare

> 10% Shareholder

VXRT

Vaxart, Inc. Healthcare

Director

AVTX

Avalo Therapeutics, Inc. Healthcare

> 10% Shareholder

ACHV

ACHIEVE LIFE SCIENCES, INC. Healthcare

> 10% Shareholder

ALIM

ALIMERA SCIENCES INC Healthcare

> 10% Shareholder

BPTH

BIO-PATH HOLDINGS INC Healthcare

> 10% Shareholder

ONTX

Onconova Therapeutics, Inc. Healthcare

> 10% Shareholder

AYTU

AYTU BIOPHARMA, INC Healthcare

Director

CYTH

Cyclo Therapeutics, Inc. Healthcare

> 10% Shareholder

BBI

Brickell Biotech, Inc. Healthcare

> 10% Shareholder

RSLS

ReShape Lifesciences Inc. Healthcare

> 10% Shareholder

TENX

TENAX THERAPEUTICS, INC. Healthcare

Director

KPRX

KIORA PHARMACEUTICALS INC Healthcare

> 10% Shareholder

AMAG

AMAG PHARMACEUTICALS, INC.

> 10% Shareholder

VLRX

Valeritas Holdings Inc.

> 10% Shareholder

DFRG

Del Frisco's Restaurant Group, Inc.

> 10% Shareholder

RSLS

ReShape Weightloss Inc.

> 10% Shareholder

INNV

INNOVUS PHARMACEUTICALS, INC.

> 10% Shareholder

ACL